General Oncology Hospital of Kifissia Agioi Anargyroi

Athens 14564

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Chemotherapy-induced Thrombocytopenia, First Line Non-Small Cell Lung Cancer, KRAS p, G12c Mutated /Advanced Metastatic NSCLC

Studies at this site

• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). — Completed
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer — Completed
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed